Results 111 to 120 of about 38,385 (346)

Comparison of efficacy and tolerability of Duloxetine vs. Gabapentin in treatment of diabetic peripheral neuropathic pain [PDF]

, 2011
Introduction: Diabetic peripheral neuropathy (DPN) is one of the most common symptomatic, long-term complications in patients with both type 1 and type 2 diabetes mellitus, and most common and most debilitating of the diabetic neuropathies. Duloxetine,
Kalantar Hormozi, Mohamadreza, Motamed, Niloufar, Salimipour, Hooman, Zarsanj, Narjes   +3 more
core  

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment

British Journal of Clinical Pharmacology, EarlyView.
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, Jia Miao   +6 more
wiley   +1 more source

Decreased microstructural integrity of the central somatosensory tracts in diabetic peripheral neuropathy

, 2021
Fang Fang, Qian Luo, Renbin Ge, Mengyu Lai, Yujia Gong, Mei Kang, Mingming Ma, Lei Zhang, Yao Li, Yufan Wang, Yongde Peng   +10 more
openalex   +1 more source

Cutting edge strategies for diabetic wound care: Nanotechnology, bioengineering, and beyond

BMEMat, EarlyView.
Graphical abstract illustrates the challenges in diabetic wound healing, covering pathophysiology, formulation hurdles, and emerging therapeutic strategies. It highlights the role of hyperglycemia, formulation complexities, and advanced technologies like bioprinting and AI in improving diabetic wound management. Abstract Diabetic wounds affect millions
Usama Ahmad, Wan Nurhidayah Wan Hanaffi, Anas Islam, Aimen Salman, Mohd Muazzam Khan, Faiyaz Shakeel, Qiang Cai, Xiaojun Cai, Quazi T. H. Shubhra   +8 more
wiley   +1 more source

Diabetic amyotrophy: Atypical presentation compared with common diabetic neuropathies. [PDF]

Can Fam Physician, 2023
Sharma A, Jattan A.
europepmc   +1 more source

Current status and future directions of botulinum neurotoxins for targeting pain processing. [PDF]

, 2015
Current evidence suggests that botulinum neurotoxins (BoNTs) A1 and B1, given locally into peripheral tissues such as skin, muscles, and joints, alter nociceptive processing otherwise initiated by inflammation or nerve injury in animal models and humans.
Pellett, Sabine, Ramachandran, Roshni, Yaksh, Tony L   +2 more
core   +2 more sources

Copper‐doped borosilicate bioactive glass coating modified bacterial cellulose functional dressing for diabetic ulcer

BMEMat, EarlyView.
For the first time, a borosilicate‐based bioactive glass coating was successfully formed on the surface of bacterial cellulose nanofibers. A copper‐doped borosilicate bioactive glass coating‐modified bacterial cellulose functional dressing was designed for the management of chronic wounds, such as diabetic ulcers.
Haiyong Ao, Dingyun Wang, Le Ma, Maohu Wang, Dongxue Zhang, Xiaowei Xun, Xidong Wu, Meili Zhang, Jiajia Zong   +8 more
wiley   +1 more source

Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis [PDF]

, 2016
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disabling autoimmune disorder of the peripheral nervous system (PNS). Intravenous immunoglobulins (IVIg) are effective in CIDP, but the treatment response varies greatly between ...
Bendszus, Martin, Cordes, Steffen, Hartung, Hans-Peter, Horste, Gerd Meyer zu, Kieseier, Bernd C., Mathys, Christian, Mausberg, Anne K., Pfaff, Johannes, Pham, Mirko   +8 more
core   +2 more sources

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

The conundrum of diabetic neuropathies-Past, present, and future. [PDF]

J Diabetes Complications, 2022
Ang L, Mizokami-Stout K, Eid SA, Elafros M, Callaghan B, Feldman EL, Pop-Busui R.   +6 more
europepmc   +1 more source